¿Por qué se nos cae el cabello?
En este Short nos preguntamos por qué razón nos cae el cabello. …
Uncategorized
Vedanta Biosciences Announces $106.5 Million Financing to Advance Pipeline of Defined Bacterial Consortia Therapies
Vedanta Biosciences today announced that it has raised $106.5 million to support pivotal-stage development of its lead candidate, VE303, for the prevention of recurrent Clostridioides difficile infection (CDI), and a Phase 2 study of VE202 for ulcerative colitis, among other development activities.
PureTech Founded Entity Vedanta Biosciences Announces $106.5 Million Financing to Advance Pipeline of Defined Bacterial Consortia Therapies
PureTech Health plc noted today that its Founded Entity, Vedanta Biosciences today announced that it has raised $106.5 million to support pivotal-stage development of its lead candidate, VE303, for the prevention of recurrent Clostridioides difficile infection (CDI), and a Phase 2 study of VE202 for ulcerative colitis, among other development activities.
Palatin Presents Data at the Association of Research in Vision and Ophthalmology 2023 Annual Conference Regarding a Potential Treatment for Glaucoma
Palatin Technologies, Inc. today announced the presentation of a poster entitled, Melanocortin Receptor Agonist PL9588 Reduces Intraocular Pressure in Normotensive Rabbits at the Association of Research in Vision and Ophthalmology (ARVO) Annual Conference.
Arrowhead Pharmaceuticals’ Proprietary Pulmonary TRiM™ Platform Achieves High Levels of Target Gene Knockdown and Long Duration of Effect
Arrowhead Pharmaceuticals’ Proprietary Pulmonary TRiM ™ Platform Achieves High Levels of Target Gene Knockdown and Long Duration of Effect.
Mawi DNA Technologies Receives 510(k) Clearance for iSWAB-Respiratory Tract Sample Collection Media-Extraction Less for SARS-CoV-2
Mawi DNA Technologies announces that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s iSWAB-Respiratory Tract Sample Collection Media-Extraction Less™ (iSWAB-RC-EL).
Breaking News: Syrebo® BCI Rehabilitation Assessment System Wins Red Dot and iF Awards Two Top Global Design Awards
Recently, the Syrebo® BCI Rehabilitation Assessment System SY-HR10A, a product of Siyi Intelligence, has won two world-renowned design awards: the Red Dot Design Award and the iF Product Design Award, attracting widespread attention from the industry.
New Publication Reveals MolecuLight Imaging Significantly Improved Detection of Bacterial Burden Across Patients of All Skin Tones
MolecuLight Inc. announced the publication of “Skin Pigmentation Impacts the Clinical Diagnosis of Wound Infection: Imaging of Bacterial Burden to Overcome Diagnostic Limitations”1 in the Journal of Racial and Ethnic Health Disparities.
AMO Pharma Announces Completion of Treatment of Last Patient in Pivotal REACH-CDM Clinical Trial in Myotonic Dystrophy
AMO Pharma Limited announced completion of treatment for the final patient enrolled in the company’s REACH-CDM clinical study of the investigational therapy AMO-02.
Micropep Demonstrates Excellent Field Efficacy for New Micropeptide Active Ingredient
Micropep Technologies, the global leader in micropeptide technology, announced successful efficacy results of its new biofungicide micropeptide ingredient during the 2022 field testing season.
Micropep Demonstrates Excellent Field Efficacy for New Micropeptide Active Ingredient Read More »